Creative Biolabs develops and commercializes a full range of integrated innovative services that are based on phage display technology. We have ...
Creative Biolabs has established custom membrane protein and membrane protein antibody production platforms for antibody discovery...
Creative Biolabs has pushed out a high-throughput B cell sorting platform, which is able to not only screen a large numbers of B-cells from humans or immunized animals but also ...
Creative Biolabs has developed the novel Hyperdoma™ platform, which is a high-throughput hybridoma generation and screening platform based on the advanced ClonePix system. We ...
Together with Creative Biomart, Creative Biolabs is the pioneer and undisputed global leader in the rapidly emerging market for biosimilars, also known as follow-on biologics (or biopharmaceuticals). We have developed a range of biosimilar stable cell lines using our proprietary gene screening and amplification system. Biosimilar cell lines are grown in suspension and produce high yields of recombinant proteins in chemically defined medium. These manufacturing cell lines have been accepted by CMO's and manufacturers worldwide to produce cGMP material.